Vaginal dryness (VD) affects both pre- and postmenopausal women at any age. Since the hormonal regulation changes during the climacteric period are considered as being the main course of the VD, affected women prefer not to talk about the problem. However, the problem does exist, and unfortunately if any, relatively minor group in the population possesses the health literacy at sufficient level to understand that VD is a suboptimal health condition which carries a multi-factorial character. Thereby, some of the contributing factors are clearly preventable and, therefore, if treated properly, have a potential to milden the VD. Current chapter demonstrates specific signs and symptoms of Flammer syndrome in women suffering from vaginal dryness, although individualised patient profiles clearly discriminate between pre- and postmenopausal women regarding the subgroup-specific symptoms. Noteworthy, about 20% of the VD patients involved in the study notify a delayed or even impaired wound healing observed for themselves over a couple of years. Optimising modifiable risk factors accompanying FS phenotype at the level of primary prevention is strongly recommended. Individualised patient profiles provide important information for VD mitigating measures tailored to the person. Further, future projects should essentially deal with the complexity of vulvar-vaginal dryness as part of the Sicca syndrome in individuals with FS phenotype, in order to prevent genital female cancers which may occur at any age. In contrast to the human papilloma virus as possible trigger of the disease, the role of the vulvar-vaginal dryness as an important risk factor is strongly underestimated in currently applied diagnostic and treatment approaches.

Breast Cancer Research Centre UKB Rheinische Friedrich Wilhelms University of Bonn Bonn Germany

Centre for Integrated Oncology UKB Cologne Bonn Rheinische Friedrich Wilhelms University of Bonn Bonn Germany

Centre of Obstetrics Gynaecology and Gynaecologic Oncology DonauIsar Klinikum Deggendorf Dingolfing Landau Germany

Department of Histology and Embryology and Biomedical Center Faculty of Medicine in Pilsen Charles University Prague Czech Republic

Department of Neurology University Hospital Pilsen Pilsen Czech Republic

Department of Obstetrics and Gynaecology Jessenius Faculty of Medicine Martin University Hospital Martin Slovak Republic

Division of Oncology Biomedical Centre Martin Jessenius Faculty of Medicine Comenius University in Bratislava Bratislava Slovak Republic

Gynaecologic Department Clinical Hospital Pheophania Kyiv Ukraine

Radiological clinic UKB Rheinische Friedrich Wilhelms University of Bonn Sigmund Freud Str 25 53105 Bonn Germany

Ultrasound Department Clinical Hospital Pheophania Kyiv Ukraine

Zabolotny Institute of Microbiology and Virology National Academy of Sciences of Ukraine Kyiv Ukraine

Zobrazit více v PubMed

Vaginal dryness [Internet]. Women’s health concern. [cited 2018 Nov 23]. Available from: https://www.womens-health-concern.org/help-and-advice/factsheets/vaginal-dryness/

Quinn-Nilas C, Milhausen RR, McKay A, Holzapfel S. Prevalence and predictors of sexual problems among midlife Canadian adults: results from a National Survey. J Sex Med. 2018;15:873–879. doi: 10.1016/j.jsxm.2018.03.086. PubMed DOI

Waetjen LE, Crawford SL, Chang P-Y, Reed BD, Hess R, Avis NE, Harlow SD, Greendale GA, Dugan SA, Gold EB, Study of Womenʼs Health Across the Nation (SWAN) Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study. Menopause. 2018;25:1094–1104. doi: 10.1097/GME.0000000000001130. PubMed DOI PMC

Gupta N, Aggarwal M, Sinha R, Varun N. Study on prevalence and severity of urogenital complaints in postmenopausal women at a tertiary care hospital. J Midlife Health. 2018;9:130–134. PubMed PMC

Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21:450–458. doi: 10.1097/GME.0b013e3182a4690b. PubMed DOI PMC

Baban B, Golubnitschaja O. The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction. EPMA J. 2017;8:333–338. doi: 10.1007/s13167-017-0107-5. PubMed DOI PMC

Moral E, Delgado JL, Carmona F, Caballero B, Guillán C, González PM, Suárez-Almarza J, Velasco-Ortega S, Nieto C, as the writing group of the GENISSE study Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018;21:167–173. doi: 10.1080/13697137.2017.1421921. PubMed DOI

Lindahl SH. Reviewing the options for local estrogen treatment of vaginal atrophy. Int J Women's Health. 2014;6:307–312. doi: 10.2147/IJWH.S52555. PubMed DOI PMC

Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J. 2017;8:17–22. doi: 10.1007/s13167-017-0086-6. PubMed DOI PMC

Ting AY, Blacklock AD, Smith PG. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod. 2004;71:1397–1404. doi: 10.1095/biolreprod.104.030023. PubMed DOI

van Lunsen RHW, Laan E. Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause. 2004;11:741–748. doi: 10.1097/01.GME.0000143704.48324.46. PubMed DOI

Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, Kurysheva N, Yao K. Flammer syndrome. EPMA J. 2014;5:11. doi: 10.1186/1878-5085-5-11. PubMed DOI PMC

Flammer Syndrome [Internet]. [cited 2018 Jul 12]. Available from: http://www.flammer-syndrome.ch/index.php?id=32

Kunin A, Polivka J, Moiseeva N, Golubnitschaja O. “Dry mouth” and “Flammer” syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach. EPMA J. 2018;9:307–317. doi: 10.1007/s13167-018-0145-7. PubMed DOI PMC

Zubor P, Gondova A, Polivka J, Kasajova P, Konieczka K, Danko J, Golubnitschaja O. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017;8:129–140. doi: 10.1007/s13167-017-0089-3. PubMed DOI PMC

Smokovski I, Risteski M, Polivka J, Zubor P, Konieczka K, Costigliola V, Golubnitschaja O. Postmenopausal breast cancer: European challenge and innovative concepts. EPMA J. 2017;8:159–169. doi: 10.1007/s13167-017-0094-6. PubMed DOI PMC

Bubnov R, Polivka J, Zubor P, Konieczka K, Golubnitschaja O. “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question. EPMA J. 2017;8:141–157. doi: 10.1007/s13167-017-0092-8. PubMed DOI PMC

Polivka Jr J, Polivka J, Pesta M, Rohan V, Celedova L, Mahajani S, Topolcan O, Golubnitschaja O. Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach. EPMA J. 2019. 10.1007/s13167-019-00162-5. PubMed PMC

Godha K, Tucker KM, Biehl C, Archer DF, Mirkin S. Human vaginal pH and microbiota: an update. Gynecol Endocrinol. 2018;34:451–5.10.1080/09513590.2017.1407753. PubMed

Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021

Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects